Anbio Biotechnology Financing Cash Flow
Anbio Biotechnology (NNNN) reported Financing Cash Flow of $6.95 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-04-07.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-04-07
| Period end | Net Cash Provided by (Used in) Financing Activities 12 month |
|---|---|
| 2025-12-31 | $6.95M 20-F · filed 2026-04-07 |
| 2024-12-31 | -$344.61K 20-F · filed 2026-04-07 |
| 2023-12-31 | -$42.84K 20-F · filed 2026-04-07 |